PowderJect

PowderJect Pharmaceuticals was a British vaccine, drug and diagnostics delivery company founded by Brian Bellhouse.

In 1993, PowderJect was spun out of the University of Oxford with the help of Isis Innovation.[1][2]

In 2003, the company was taken over by the American Chiron Corporation for £542 million.[3][4] The company's CEO was Paul Drayson, Baron Drayson, son-in-law of the founder, Brian Bellhouse, and they received £100 million following the takeover.[3][4] Drayson received £43m for his 8% holding, Bellhouse £19.5m for his 3.6% stake, and their family trusts received £41m.[4]

References
  1. Elliott, Francis (14 April 2002). "Labour donor is no stranger to controversy". Telegraph. Retrieved 29 June 2017.
  2. Andrew Clark (19 January 2002). "Interview: Paul Drayson, Powderject Pharmaceuticals | Business". The Guardian. Retrieved 29 June 2017.
  3. Fletcher, Richard (27 April 2003). "PowderJect to be sold for £500m". Daily Telegraph. UK. Retrieved 27 June 2017.
  4. Geoffrey Gibbs (20 May 2003). "£43m windfall for PowderJect chief | Business". The Guardian. Retrieved 27 June 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.